株式会社Arktus Therapeutics
1 known investors
Arktus develops regenerative medicine using iPS cell-derived cartilage implants for knee cartilage repair, combining iPS cell research from Kyoto University with cell 3D-printing technology from Saga University. The company aims to provide patient-specific treatment for knee pain and to extend healthy and athletic lifespans.
Founders & leadership
TO
Tomohiro OiwaRepresentative Director (CEO)
KN
Koichi NakayamaOutside Director / Professor, Saga University School of Medicine
MI
Makoto IkeyaOutside Director / Associate Professor, Kyoto University CiRA (iPS Cell Research Institute)
Investors · 1
Frequently asked questions
- What does 株式会社Arktus Therapeutics do?
- Arktus develops regenerative medicine using iPS cell-derived cartilage implants for knee cartilage repair, combining iPS cell research from Kyoto University with cell 3D-printing technology from Saga University. The company aims to provide patient-specific treatment for knee pain and to extend healthy and athletic lifespans.
- Who are 株式会社Arktus Therapeutics's investors?
- 株式会社Arktus Therapeutics's investors include Kyoto University Innovation Capital.